Preclinical studies of the new oral Traveler’s diarrhea vaccine shows that it is safe and immunogenic
Results from preclinical evaluation of the new multivalent, oral Traveler’s diarrhea vaccine was recently published.The vaccine was studied for immunogenicity and safety in mice and was well tolerated and induced a strong intestinal immune response to all vaccine components.